Germline testing of DNA from cultured skin fibroblasts reveled a deletion of exons 5-6 of the RUNX1 gene, classified as P by ACMG Myeloid Malignancy Variant Curation Expert Panel (MM-VCEP) criteria [9]. The gene discussed is RUNX1; the disease is myeloid neoplasm.